Australia + New Zealand

Momentum Clinical Research: Faster starts. Faster results. Clinical excellence. The only Trans-Tasman research network. 

Australia + New Zealand

The Largest Network in the Trans-Tasman

Experienced teams. Experienced management.

In the complicated world of clinical trials, we strive to make things easy, using our decades of experience and size to our advantage – and yours.


Momentum Clinical Research in the Spotlight

Stay at the forefront of the latest happenings, breakthroughs, collaborations, and milestones at Momentum Clinical Research. Here, we chronicle our journey, celebrate our achievements, and share insights that shape the world of clinical trials.

August 22, 2023

AusTrials Celebrates the Grand Opening of New Clinical Research Site – AusTrials Sunshine

AusTrials welcomed the Mayor of Brimbank, Councillor Bruce Lancashire and around 60 guests to the official opening of our newest site located in the Sunshine Private Hospital, St Albans in Melbourne’s west. The state-of-the-art facility, named AusTrials Sunshine, will mark the expansion of AusTrials from Queensland into Victoria and enhance medical research in the region. 

Read full article

September 6, 2023

P3 at the NZACRES conference 2023

P3 Research was a proud gold sponsor at the recent NZACRes 2023 conference in Auckland. Two members of staff from each of our seven P3 units, and from our head office joined in, making great connections with colleagues, sponsors, and peers in the clinical research field. Congratulations to the NZACRes committee and conference committee, for a very good conference.

Read full article

Momentum Capabilities

Embarking on a clinical trial is a profound decision. It’s an amalgamation of faith, science, and hope. At Momentum, we understand this. Our distinctive advantages ensure that every trial we undertake is a step towards a brighter medical future.

Accelerated Startup

Patient recruitment is still the biggest challenge in clinical trials and Momentum is setting a world leading standard by leveraging years of experience in marketing and patient engagement strategies. The geographically diverse and dispersed locations of our sites give our partners an advantage in reaching a larger number of participants in a shorter period of time. By providing a seamless experience from engagement through to completion, we’ve built a comprehensive database of over 50,000 participants, enabling us to deliver high-quality study data as quickly and efficiently as possible.

Additionally, our Australian and New Zealand based teams are experienced in streamlined ethics processes, allowing for a fast-tracked approval time of four to six weeks.

Consistent Quality Outcomes

For over 20 years, Momentum’s key personnel have worked alongside the most experienced investigators and researchers across Australia and New Zealand to successfully deliver more than 200 Phase Ib-IV clinical trials. Our facilities are equipped with the latest medical technology and all staff are proficient in the leading electronic case report forms and randomisation platform software. Momentum allocates a dedicated quality officer to all clinical trials, to ensure they comply with the International Council for Harmonisation (ICH) E6 Good Clinical Practice (GCP) and collect high quality and credible data. We take pride in upholding the highest clinical trial standards with our GCP trained teams and IATA certified staff.

Diverse Therapeutic Capabilities

Since 2001, we have demonstrated our commitment to innovation and quality, and our widespread presence across Australia and New Zealand makes us the only Trans-Tasman clinical research network. Momentum’s portfolio of 13 sites through the merging of P3 Research, AusTrials and Holdsworth House bring an unparalleled diversity of research experience and therapeutic capabilities. We can facilitate individual trials to be conducted across multiple sites, reducing the need for sponsors to co-ordinate numerous parties – resulting in a smoother trial process.

Single Point of Contact

By partnering with Momentum, trial sponsors can expect a single point of contact from feasibility assessment through to trial completion. With our 48-hour initial response time, a dedicated team will provide consistent communication throughout the trial process, ensuring partners receive fast responses to enable timely decision-making and provide regular stakeholder updates. Our end-to-end support system allows for efficiency during the intricate clinical trial journey to ensure sponsors experience consistent, first-class care from the onset.

our brands

p3 research

New Zealand

New Zealand - P3 Research Making Patients the Priority

Learn more about P3

“In the heart of every clinical trial lies the promise of progress. With P3, we’re ensuring that progress puts patients first.”

– Dr Richard Stubbs [Managing Director of P3]
  • Bespoke Patient Programs: Tailored care paths for the best patient outcomes.
  • Data-driven: Harnessing real-world evidence for optimal patient care.
  • Connected Health Platforms: Linking doctors, patients, and healthcare systems.



Leading the Way in Clinical Research Integrity and Efficiency

Learn more about AusTrials

“Clinical research is the foundation of medical advancement. At AusTrials, we’re committed to pushing the boundaries of medicine, ethically and efficiently.”

Dr Munro Neville [Managing Director of AusTrials]
  • Ethics Submissions: Expertise with Bellberry Human Research Committee submissions.
  • Research Governance: RGO/Management Committee ensuring high standards.
  • Advanced Sites & Facilities: Designed for a seamless patient experience, equipped with state-of-the-art examination rooms, laboratories, and pharmacy rooms.



One of Australias most ambitious research units 

Learn more about Holdsworth House

“As a group we are dedicated to making a difference by shaping the future of medicine and embracing the opportunity to contribute to groundbreaking research.”

Prof Mark Bloch [Director of Clinical Research, Holdsworth House Research]
  • Ethics Submissions: Expertise with Bellberry Human Research Committee submissions.
  • Research Governance: RGO/Management Committee ensuring high standards.
  • Advanced Sites & Facilities: Designed for a seamless patient experience, equipped with state-of-the-art examination rooms, laboratories, and pharmacy rooms.

Why Clinical Research Organisations Choose Momentum

In the vast landscape of clinical trials, making a choice can be overwhelming. But leading Clinical Research Organisations have consistently chosen Momentum. Why?

Streamlined Processes

Navigating the maze of clinical trial administration can be challenging. Our processes, perfected over the years, ensure that every phase of the trial, from inception to completion, is seamless.

Cutting-Edge Infrastructure

Our facilities, equipped with the latest in medical technology, ensure that every trial is backed by the best in research tools and methodologies.


A Dedicated Team

At the heart of Momentum is its team. A blend of experienced stalwarts and dynamic young talents, our professionals are driven by a single purpose – to make every trial a success story.

Ethical Commitment

Our commitment to ethics is unwavering. Every trial we undertake adheres to the highest standards of medical ethics, ensuring the safety, well-being, and dignity of our participants.

Unified Excellence

The combination of P3 and AusTrials brings together unmatched expertise in clinical research and patient care.

A Comprehensive Approach

Our end-to-end services range from customised patient programs to robust research governance, ensuring CROs experience streamlined, top-notch collaboration.

Quality Assurance

We’re not just about research; we’re about setting and upholding the pinnacle of standards in every endeavor.

And much more

These are a simple overview of the “why” our network and sites are often preferred partners. Get in touch and we will tell you more about all we can do together.

Discover a world where clinical trials are more than just research; they’re a mission.

Explore Momentum Research Group – where the future of medical advancement is being written.

Contact us

our vision

To revolutionise healthcare by bridging clinical research and exceptional patient care, ensuring patients remain at the heart of all we do.